Inspection Record

Delta Pharma Inc. — Health Canada Inspection Findings

Health CanadaInspected 2022-05-31 7 findingsComputer system validationOther quality systemCleaning validationTraining and personnelDeviation, CAPA, and investigationLabeling and packagingComplaint and recall handling

View the regulator's official source The source document is always the basis for judgement.

Findings

1Computer system validation

The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate. The controls were inadequate for creating, modifying, reviewing, storing, and/or retrieving records. The establishment and/or the maintenance of a data governance plan was inadequate.

2Other quality system

The traceability, legibility, documentation, formatting, and/or the accuracy of records was inadequate.

3Cleaning validation

The implementation, effectiveness, and/or validation of the cleaning procedures was inadequate for preventing unsanitary conditions.

4Training and personnel

The job descriptions for personnel, the authority given to personnel, and/or the delegation of duties was inadequate and/or undocumented.

5Deviation, CAPA, and investigation

The evaluation was inadequate for cases where there was a deviation from the norm and/or where products were on the borderline of the acceptable range.

6Labeling and packaging

The quality agreement outlining the responsibilities for fabricating, packaging or labelling, and/or testing was inadequate.

7Complaint and recall handling

The assessment, recording, follow-up, and/or investigation of complaints and/or other information about potentially defective products was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2022-05-31. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Delta Pharma Inc. company profile — full history Health Canada documents, 2022 Go to Findings search